Aquatic Capital Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.32M | Buy |
42,000
+26,893
| +178% | +$1.49M | 0.05% | 437 |
|
|
2025
Q1 | $731K | Buy |
+15,107
| New | +$731K | 0.02% | 677 |
|
|
2024
Q2 | – | Sell |
-2,300
| Closed | -$66.5K | – | 1526 |
|
|
2024
Q1 | $66.5K | Sell |
2,300
-6,400
| -74% | -$185K | ﹤0.01% | 992 |
|
|
2023
Q4 | $199K | Buy |
8,700
+200
| +2% | +$4.58K | 0.01% | 848 |
|
|
2023
Q3 | $142K | Buy |
8,500
+7,400
| +673% | +$124K | 0.01% | 756 |
|
|
2023
Q2 | $30K | Buy |
+1,100
| New | +$30K | ﹤0.01% | 1073 |
|
|
2023
Q1 | – | Sell |
-22,300
| Closed | -$243K | – | 1665 |
|
|
2022
Q4 | $243K | Buy |
+22,300
| New | +$243K | 0.02% | 698 |
|